[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370556-105":59,"doc-detail-370556-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","decoding-the-complexity-mechanistic-insights-into-comorbidities-in-idiopathic-pulmonary-fibrosis","Decoding the complexity - mechanistic insights into comorbidities in idiopathic pulmonary fibrosis","","The complex pathogenic relationships between idiopathic pulmonary fibrosis (IPF) and its usually associated comorbidities remain insufficiently understood. Evidence suggests bidirectional influence may occur, yet whether associations are causal or driven by shared risks such as ageing, smoking, lifestyle, and genetic susceptibility is unclear. Some comorbidities appear before IPF, whereas others emerge after onset, indicating potential directional relationships. Multiple concurrent comorbidities may interact and amplify disease progression. The review synthesizes mechanistic pathways, shared pathobiology, and causal insights from methods such as Mendelian randomisation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/decoding-the-complexity-mechanistic-insights-into-comorbidities-in-idiopathic-pulmonary-fibrosis/370556/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/decoding-the-complexity-mechanistic-insights-into-comorbidities-in-idiopathic-pulmonary-fibrosis/370556.png","ImageObject",300,407,{"name":92,"@type":93},"Aria Callaghan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What makes the relationship between IPF and comorbidities difficult to interpret?","Question",{"text":113,"@type":114},"Associations may be causal or may arise independently from shared risk factors such as ageing, smoking, lifestyle, and genetic susceptibility. Patients also often have multiple comorbidities that can interact and worsen outcomes.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do timing patterns of comorbidities relate to their association with IPF?",{"text":118,"@type":114},"Some comorbidities (e.g., metabolic syndromes, GORD, OSA) precede IPF onset, while others (e.g., pulmonary hypertension, lung cancer) often become evident after IPF develops or during progression. These patterns suggest directional relationships.",{"name":120,"@type":111,"acceptedAnswer":121},"Which research approaches are used to clarify whether comorbidities are causally linked to IPF?",{"text":122,"@type":114},"The review notes the use of causal inference methods such as Mendelian randomisation and exploration of underlying mechanisms, though results have not yet produced conclusive insights.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},370556,1790798203,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":56,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},962084926284,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","EUROPEAN RESPIRATORY JOURNAL REVIEW  \nM. SELMAN ET AL.  \nDecoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis  \nMoisés Selman  Ivette Buendia-Roldan  and Annie Pardo  \n\n| Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis |\n| --- |\n| \u003Cbr>Shared gene variants Subendocardium hypoxaemia\u003Cbr>Cellsenescence\u003Cbr>Microaspirations Shared gene variants\u003Cbr>Fibrosis extent Endothelial dysregulation |\n\n\n| GRAPHICAL ABSTRACT In this review, we | provide a general overview of the relationship | between idiopathic pulmonary | fibrosis and its |\n| --- | --- | --- | --- |\n| comorbidities, emphasising the pathogenic randomisation studies. | mechanisms, potential shared pathobiology and, | where relevant, causal insights | from Mendelian |\n|  |  |  |  |\n\n[https://doi.org/10.1183/13993003.02418-2024](https://doi.org/10.1183/13993003.02418-2024) Eur Respir J 2025; 65: 2402418  \nEUROPEAN RESPIRATORY JOURNAL REVIEW  \nM. SELMAN ET AL.  \nDecoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis  \nMoisés Selman 1, Ivette Buendia-Roldan 1 and Annie Pardo2  \n1 Instituto Nacional de Enfermedades Respiratorias “Ismael Cosío Villegas”, Mexico City, Mexico. 2 Facultad de Ciencias, Universidad Nacional Autónoma de México, Mexico City, Mexico.  \nCorresponding author: Moisés Selman ([mselmanl@yahoo.com. mx](mselmanl@yahoo.com. mx))  \nShareable abstract (@ERSpublications)  \nUnderstanding the connections between IPF and its comorbidities is essential and could help to identify factors that enhance early diagnosis and improve patient outcomes [https://bit.ly/4izn3NT](https://bit.ly/4izn3NT)  \nCite this article as: Selman M, Buendia-Roldan I, Pardo A. Decoding the complexity: mechanistic insights into comorbidities in idiopathic pulmonary fibrosis. Eur Respir J 2025; 65: 2402418 [DOI: 10 . 1183/13993003 .02418-2024] .  \nCopyright ©The authors 2025 .  \nThis version is distributed under the terms of the Creative Commons Attribution NonCommercial Licence 4 .0. For commercial reproduction rights and permissions contact [permissions@ersnet.org](permissions@ersnet.org)  \nReceived: 7 Dec 2024  \nAccepted: 12 March 2025  \nAbstract  \nThe complex pathogenic relationships between idiopathic pulmonary fibrosis (IPF) and its usually associated comorbidities remain poorly understood. While evidence suggests that some comorbidities may directly influence the development or progression of IPF, or vice versa, whether these associations are causal or arise independently due to shared risk factors, such as ageing, smoking, lifestyle and genetic susceptibility, is still uncertain. Some comorbidities, such as metabolic syndromes, gastro-oesophageal reflux disease and obstructive sleep apnoea, precede the development of IPF. In contrast, others, such as pulmonary hypertension and lung cancer, often become apparent after IPF onset or during its progression. These timing patterns suggest a directional relationship in their associations. The issue is further complicated by the fact that patients often have multiple comorbidities, which may interact and exacerbate one another, creating a vicious cycle. To clarify these correlations, some studies have used causal inference methods (e.g. Mendelian randomisation) and exploration of underlying mechanisms; however, these efforts have not yet generated conclusive insights. In this review, we provide a general overview of the relationship between IPF and its comorbidities, emphasising the pathogenic mechanisms underlying each comorbidity, potential shared pathobiology with IPF and, when available, causal insights from Mendelian randomisation studies.  \nIntroduction  \nComorbidities are frequent in patients with idiopathic pulmonary fibrosis (IPF) and have a marked influence in the clinical course and outcome of the disease [1] . Thus, their inclusion, mainly pulmonary hypertension (PH) and lung cancer, may help to predict","cbCaiezrZV2ti98W","https://ap.wps.com/l/cbCaiezrZV2ti98W","pdf",1316048,"English","# Abstract\n# Introduction","[{\"question\":\"What makes the relationship between IPF and comorbidities difficult to interpret?\",\"answer\":\"Associations may be causal or may arise independently from shared risk factors such as ageing, smoking, lifestyle, and genetic susceptibility. Patients also often have multiple comorbidities that can interact and worsen outcomes.\"},{\"question\":\"How do timing patterns of comorbidities relate to their association with IPF?\",\"answer\":\"Some comorbidities (e.g., metabolic syndromes, GORD, OSA) precede IPF onset, while others (e.g., pulmonary hypertension, lung cancer) often become evident after IPF develops or during progression. These patterns suggest directional relationships.\"},{\"question\":\"Which research approaches are used to clarify whether comorbidities are causally linked to IPF?\",\"answer\":\"The review notes the use of causal inference methods such as Mendelian randomisation and exploration of underlying mechanisms, though results have not yet produced conclusive insights.\"}]","Decoding the complexity - mechanistic insights into comorbidities in idiopathic pulmonary fibrosis | PDF",1790189113,48,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e159b7fd9c81bccd3a6c110c513477f.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d61acd94224f5c045d342b25d9be95d1.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a4d80ce294129ddaf862037dfb6bf4d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2895b9cfff8fc514ba5853dc43515162.webp",980,1306]